Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss current data on the use of perioperative systemic therapy in patients with resectable colorectal liver metastases
- Describe prospects for long-term survival in patients who undergo resection of colorectal liver metastases
- Summarize data on use of targeted biologic agents in combination with other agents in the treatment of metastatic colorectal cancer
- Explain the rationale for KRAS tumor testing in patients who are candidates for therapy with epidermal growth factor receptor antibodies
Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.